Article Figures & Data
Figures
- Figure 1.
Change in compliance with American Academy of Pediatrics guidelines for mothers receiving antibiotics for suspected chorioamnionitis. CBC, complete blood count.
- Figure 2.
Change in compliance with American Academy of Pediatrics guidelines for mothers receiving intrapartum antibiotic prophylaxis (IAP) for group B streptococcal (GBS) disease. *P < .0001. †P < .005. CBC, complete blood count.
Tables
Outcome Old Nursery Orders New Nursery Orders Hepatitis B virus vaccination Physicians must “opt in,” ie, specifically order the vaccine Physicians must “opt out,” ie, specifically order that no vaccine be given Discharge follow-up recommendations No guidance Recommendations based on infant's age at discharge, transcutaneous bilirubin result before discharge, and jaundice risk factors, including breastfeeding. Follow-up intervals based on AAP recommendations.4 GBS disease prevention If the mother was positive for GBS, infant's vital signs were measured more frequently Follow CDC recommendations including observation for 48 hours for many infants.2Orders differ from CDC guideline by requiring only complete blood counts, and not blood cultures, for certain infants. -
GBS, group B streptococcal; AAP, American Academy of Pediatrics; CDC, Centers for Disease Control and Prevention.
-
Statistic 2007 (n = 434) 2008 (n = 423) Infant Sex Male n (%) 221 (51) 208 (49) Birth weight (g) Mean (SD) 3407 (510.7) 3416 (505.6) Range 1814–4990 1980–4884 Singleton birth n (%) 425 (98) 415 (98) APGAR score at 1 minute Mean (SD) 8 (1.4) 8 (1.4) Range 1 to 10 1 to 9 APGAR score at 5 minutes Mean (SD) 9 (0.5) 9 (0.5) Range 5 to 10 4 to 10 Method of birth Vaginal n (%) 306 (71) 297 (70) Assisted vaginal n (%) 20 (5) 14 (3) Caesarean section n (%) 108 (25) 112 (26) Length of stay (hours) Median (SD) 54 (96.3) 52 (60.5) Range 13 to 1754 15 to 917 <24 n (%) 1 (0.2) 3 (1) 24–47 n (%) 152 (35) 158 (37) 48–72 n (%) 160 (37) 149 (35) >72 n (%) 121 (28) 113 (27) Maternal age (years) Mean (SD) 29 (6.1) 29 (6.2) Range 15 to 50 15 to 46 Maternal education (years) 0–12 n (%) 195 (45) 183 (43) 13–16 n (%) 133 (31) 135 (32) 17+ n (%) 106 (24) 105 (25) Maternal race White n (%) 189 (44) 214 (51) Black n (%) 127 (29) 119 (28) American Indian n (%) 19 (4) 9 (2) Asian n (%) 42 (10) 47 (11) Other n (%) 75 (17) 47 (11) Unknown n (%) 2 (0.5) 4 (1) Paternal race White n (%) 178 (41) 199 (47) Black n (%) 142 (33) 116 (27) American Indian n (%) 9 (2) 7 (2) Asian n (%) 38 (9) 42 (10) Other n (%) 72 (17) 50 (12) Unknown n (%) 12 (3) 24 (6) Father Hispanic Yes n (%) 61 (14) 51 (12) No n (%) 349 (80) 347 (82) Missing n (%) 24 (6) 25 (6) Mother Hispanic Yes n (%) 67 (15) 52 (12) No n (%) 354 (82) 366 (87) Missing n (%) 13 (3) 5 (1) Father birthplace United States n (%) 229 (53) 240 (57) Somalia n (%) 56 (13) 46 (11) Other n (%) 149 (34) 137 (32) Mother birthplace United States n (%) 251 (58) 267 (63) Somalia n (%) 60 (14) 51 (12) Other n (%) 123 (28) 105 (25) Prenatal visits Mean (SD) 10.3 (3.2) 10.7 (3.0) Range 1 to 24 0 to 21 EGA (weeks) Mean (SD) 39.4 (1.3) 39.4 (1.5) Range 35.3 to 42.3 35 to 43.6 Maternal diabetes n (%) 40 (9) 34 (8) -
EGA, estimated gestational age.
-
2007 2008 LOS <24 hours n = 1 n = 3 Clinic follow-up (days) 1–5* 1 (100) 2 (67) ≥7† 0 0 LOS 24–47 hours n = 152 n = 155 Clinic follow-up (days) 1 to 5* 130 (86) 140 (90) ≥7† 9 (6) 8 (5) LOS 48–72 hours n = 151 n = 138 Clinic follow-up (days) 1–5* 129 (85) 120 (87) ≥7† 10 (7) 9 (7) LOS >72 hours n = 90 n = 81 Clinic follow-up (days) 1–5* 69 (77) 74 (91) ≥7† 10 (11) 3 (4) All‡ n = 394 n = 377 Clinic follow-up 1–5* 329 (84) 336 (89) ≥7† 29 (7) 20 (5)
